NuCana plc logo

NCNANuCana plc

NCNA Stock Price, Valuation & Chart | NuCana plc

Compare

NCNA Historical price chart

NCNA Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization8.44M
PE Ratio-0.47
EPS-2.98
Trading Volume50.53K
Today's High/Low1.43/1.33
Dividend Yield0.00
52 Week High/Low7.22/1.21
Shares Outstanding6.07M
NCNA Financial Statement
NCNA Analyst ratings
NCNA Analysis & performance metrics

NCNA Company profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its…

NCNA Management team

Management
Martin Alexander Quinn
Company Secretary
Hugh Stephen GriffithCEO
Founder, Chief Executive Officer & Executive Director
David Harrison
Head of Translational Medicine & Studies
Theresa Bruce
Senior Vice President of Clinical Operations
Elisabeth Oelmann
Senior Vice President of Medical & Clinical Development
Gordon Kennovin
Senior Vice President of CMC & Development
Jeffrey D. Bloss F.A.C.O.G., M.D.
Chief Medical Officer
Stuart Grant
Senior Vice President of Regulatory Affairs
Total 8 executives

NCNA Frequently asked questions

What is NuCana plc (NCNA) Stock Price?

Current stock price of NuCana plc (NCNA) stock is $1.390. The stock price is +0.72% higher in the session. The intraday range can be seen from this page. Volume of NuCana plc (NCNA) stock is 50.53K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the NuCana plc (NCNA) stock price going up or down today?

The stock price of NuCana plc (NCNA) can change with earnings, company news, and overall market sentiment. NuCana plc operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the NuCana plc stock expensive at its current price?

Whether NuCana plc looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NCNA on this page is -0.47. EPS on this page is -2.98. Compare those figures with peers and growth expectations before deciding if the current NuCana plc price is justified.

How has the stock price of NuCana plc (NCNA) performed historically?

Historical performance for NuCana plc (NCNA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NCNA reacted to past earnings and market events.

Should I buy NuCana plc (NCNA) stock, at this price?

Buying NuCana plc (NCNA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.